InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Thursday, 05/30/2019 8:57:50 AM

Thursday, May 30, 2019 8:57:50 AM

Post# of 345950
I wonder how many biotech companies have sent into the FDA live 3D images at the cellular level in support of their respective drugs Mechanism of Action. Flipped PS is becoming a nightmare to witness firsthand and geez, actual imaging proves some MOAs are correct and many MANay others flawed. Let us await to see some of the pending lobbyist initiatives surrounding Biomarkers. A picture is worth a thousand words and a thousand words from a Big Pharma lobbyist is not worth much at all.

Flipped PS aka PtdSer aka Phosphatidylserine thresholds, control much of the most important protein pathway biomarkers.

Imagine that, half of the FDA approved drugs can be tossed out the window and welcomes PS Targeting

David Mott
https://www.nea.com/team/david-mott

Scott Gottlieb
https://www.nea.com/team/scott-gottlieb-md

New Enterprise Associates – which has locations in Chevy Chase, Maryland, Menlo Park, California, and others – said Wednesday that it had rehired former FDA Commissioner Scott Gottlieb as a special partner. Gottlieb had previously served as venture partner at the firm from 2007 until 2017, when he was appointed as the country’s top drug regulator. He stepped down as FDA commissioner in March, and Ned Sharpless – former director of the National Cancer Institute – currently serves in his place as acting commissioner. Following his resignation, Gottlieb also returned to another prior position, as a fellow at conservative think tank the American Enterprise Institute.
https://medcitynews.com/2019/05/scott-gottlieb-returns-to-nea-this-time-with-some-valuable-experience-under-his-belt/

Good afternoon Mr Gottlieb, we were wondering if you had any information regarding Peregrine Pharmaceuticals or the advances being made and any possible filings with the FDA?

SG: I am sorry to say that I can't comment on those matters.

Yes we assumed that would be the response, how about having your old job back and a nice signing bonus?

SG: I am still tied to the agency...the FDA...you know?

Well we have some plans that would benefit you nicely, if you decided to resign from the agency and no laws prohibiting you from waiting 30 days and move forward with our plans?

SG: Thanks for the offer but I have no reason to leave the FDA at this time.

Think about it and you can always leave as cover due to e-cigs / vaping and we can even help you in support of those addictions to teenagers etc if you can help us?

SG : Help with what?

Well we can set up a meeting with David Mott and yourself if you decide to leave the FDA... these biomarkers for Immunotherapy are a major concern.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News